CLINICAL

MS Group Praises New Drug Despite High Price Tag
MS Group Praises New Drug Despite High Price TagWhy a drug that costs $65,000 a year is making patient groups happy.
GSK Issues Voluntary Recall
GSK Issues Voluntary RecallNearly 600,000 inhalers are being recalled.
EpiPen and EpiPen Jr. Recalled: Recall Expanded from Europe and AsiaTwo previous reports of device failures lead EpiPen maker to expand recall to the United States.
The Full Extent of Antibiotic Use in the United States? No One Knows.
The Full Extent of Antibiotic Use in the United States? No One Knows.What we know—and what we don't—about antibiotics in America.
WHO Launches Program to Reduce Medication ErrorsHow a program hopes to cut errors in half.
As More Canadian Provinces Mandate Error Reporting, U.S. Experts Call for Similar LawsOntario joins Nova Scotia in making medication dispensing error reporting mandatory, but no states have enacted similar laws.
The Health Economics of Medical Pot and the Pharmacist’s Role
The Health Economics of Medical Pot and the Pharmacist’s RoleEven medical marijuana has health-care costs and outcomes.
What to do About Rising Health-Care Costs?
What to do About Rising Health-Care Costs?Taking a clear-eyed look at the cost of health care can reduce waste.
What’s in the Specialty Pharmacy Pipeline?
What’s in the Specialty Pharmacy Pipeline?Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.
New York City Program Aims to Slash Opioid Deaths
New York City Program Aims to Slash Opioid DeathsWhat New York City is doing to curb the opioid epidemic.

Poll